diclofenac has been researched along with Intraocular Pressure in 51 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Intraocular Pressure: The pressure of the fluids in the eye.
| Excerpt | Relevance | Reference |
|---|---|---|
| "PRéCIS:: Adjuvant diclofenac and apraclonidine eye drop given in conjunction with selective laser trabeculoplasty (SLT) do not significantly impact medium-term intraocular pressure (IOP) reduction compared with placebo, but apraclonidine can be used to blunt immediate postlaser pressure spikes." | 9.34 | Effect of Apraclonidine and Diclofenac on Early Changes in Intraocular Pressure After Selective Laser Trabeculoplasty. ( Bergo, C; Halvorsen, H; Krohn, J; Thrane, AS; Thrane, VR, 2020) |
| "To evaluate the comparative effects and safety of topical diclofenac sodium, fluorometholone, and dexamethasone for controlling inflammation after routine strabismus surgery." | 9.27 | A Randomized Clinical Trial of Topical Diclofenac, Fluorometholone, and Dexamethasone for Control of Inflammation After Strabismus Surgery. ( Bae, S; Choi, DC; Choi, DG; Kim, J; Lee, JY, 2018) |
| "Intravitreal diclofenac is effective in the treatment of diffuse diabetic macular edema up to 12 weeks." | 9.15 | Intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema. ( Elbendary, AM; Shahin, MM, 2011) |
| "VA in both the diclofenac- and betamethasone-treated eyes significantly improved following the cataract surgery; however, no statistical difference of VA was noted between the diclofenac- and betamethasone-treated eyes throughout the observational period (before and after the surgery until 8 weeks postoperatively)." | 9.12 | Diclofenac prevents an early event of macular thickening after cataract surgery in patients with diabetes. ( Nakazawa, T; Nishida, K; Shimura, M; Yasuda, K, 2007) |
| " The concurrent administration of nonsteroidal anti-inflammatory drug such as diclofenac prevents these adverse effects without interfering with the drop in intraocular pressure caused by timolol." | 9.09 | Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia. ( Akura, J; Ibaraki, N; Ichihashi, S; Maekubo, K; Miyake, K; Miyake, S; Ota, I; Shibuya, Y, 2001) |
| "Latanoprost therapy enhances disruption of the blood-aqueous barrier and increases the incidence of angiographic CME formation in early postoperative pseudophakias." | 9.09 | Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias. ( Ichihashi, S; Maekubo, K; Miyake, K; Miyake, S; Ota, I, 1999) |
| "To evaluate effects of topical ophthalmic administration of diclofenac on intraocular pressure (IOP) when applied at 4 frequencies to eyes of Beagles." | 7.96 | Effect of topical administration of 0.1% diclofenac sodium ophthalmic solution at four frequencies on intraocular pressure in healthy Beagles. ( Colussi, JA; Henriksen, ML; Lappin, MR; Martabano, BB; Sharp, JL; Wang, Z, 2020) |
| "To evaluate the effect of a single dose of intravitreal diclofenac on macular edema (ME) due to branch retinal vein occlusion (BRVO)." | 7.83 | Intravitreal Diclofenac in the Treatment of Macular Edema Due to Branch Retinal Vein Occlusion. ( Arora, S; Ghosh, B; Gupta, A; Raina, UK; Seth, A, 2016) |
| "Forty-two diabetic patients and 50 normal control patients who underwent small-incision phacoemulsification cataract surgery bilaterally received topical preservative-free diclofenac in 1 eye and preserved diclofenac in the other eye." | 7.78 | A comparison of preservative-free diclofenac and preserved diclofenac eye drops after cataract surgery in patients with diabetic retinopathy. ( Miyazawa, A; Shimura, M; Yasuda, K, 2012) |
| "To investigate the mechanism by which pilocarpine causes increased aqueous humor (AH) flare, hypotony, and miosis in dogs." | 7.70 | Inhibition of pilocarpine-induced aqueous humor flare, hypotony, and miosis by topical administration of anti-inflammatory and anesthetic drugs to dogs. ( Gionfriddo, J; Krohne, SG; Morrison, EA, 1998) |
| "Diclofenac was more effective than betamethasone in preventing angiographic CME and BAB disruption after small-incision cataract surgery." | 6.73 | Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethason ( Asano, S; Kimura, W; Miyake, K; Ota, I; Sakka, Y; Sugita, G; Yabe, N, 2008) |
| "Diclofenac-treated patients exhibited a marked fall in intraocular pressure (p<0." | 6.71 | The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients. ( Antinozzi, PP; Caccavale, A; Costagliola, C; Cotticelli, L; Parmeggiani, F; Sebastiani, A, 2005) |
| "PRéCIS:: Adjuvant diclofenac and apraclonidine eye drop given in conjunction with selective laser trabeculoplasty (SLT) do not significantly impact medium-term intraocular pressure (IOP) reduction compared with placebo, but apraclonidine can be used to blunt immediate postlaser pressure spikes." | 5.34 | Effect of Apraclonidine and Diclofenac on Early Changes in Intraocular Pressure After Selective Laser Trabeculoplasty. ( Bergo, C; Halvorsen, H; Krohn, J; Thrane, AS; Thrane, VR, 2020) |
| "To evaluate the comparative effects and safety of topical diclofenac sodium, fluorometholone, and dexamethasone for controlling inflammation after routine strabismus surgery." | 5.27 | A Randomized Clinical Trial of Topical Diclofenac, Fluorometholone, and Dexamethasone for Control of Inflammation After Strabismus Surgery. ( Bae, S; Choi, DC; Choi, DG; Kim, J; Lee, JY, 2018) |
| "In this preliminary study, diclofenac sodium is at least as good as topical dexamethasone phosphate for glaucoma patients undergoing two-site combined phacotrabeculectomy with mitomycin C." | 5.17 | Postoperative treatment with topical diclofenac versus topical dexamethasone after combined phacotrabeculectomy with mitomycin C. ( Goldenfeld, M; Kalev-Landoi, M; Katz, G; Levkovitch-Verbin, H, 2013) |
| "Long-term prospective studies are needed to study the effect of topical treatment with latanoprost on the consequences of retinal hyperperfusion in retinal vascular diseases such as diabetic retinopathy." | 5.16 | Topical treatment for 1 week with latanoprost but not diclofenac reduces the diameter of dilated retinal arterioles in patients with type 1 diabetes mellitus and mild retinopathy. ( Bek, T; Tilma, KK, 2012) |
| "Intravitreal diclofenac is effective in the treatment of diffuse diabetic macular edema up to 12 weeks." | 5.15 | Intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema. ( Elbendary, AM; Shahin, MM, 2011) |
| "VA in both the diclofenac- and betamethasone-treated eyes significantly improved following the cataract surgery; however, no statistical difference of VA was noted between the diclofenac- and betamethasone-treated eyes throughout the observational period (before and after the surgery until 8 weeks postoperatively)." | 5.12 | Diclofenac prevents an early event of macular thickening after cataract surgery in patients with diabetes. ( Nakazawa, T; Nishida, K; Shimura, M; Yasuda, K, 2007) |
| "To determine whether a topical ophthalmic diclofenac sodium formulation containing a proprietary polymeric drug delivery system (ISV-205), when dosed concomitantly with 1% prednisolone acetate, is effective in blocking the intraocular pressure (IOP) response in humans." | 5.10 | Prevention of corticosteroid-induced intraocular pressure elevation using ISV-205. ( Stewart, WC, 2003) |
| "Dexamethasone and diclofenac were equally effective in reducing postoperative inflammation after phacoemulsification and IOL implantation in eyes with no other disease than cataract." | 5.10 | Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery. ( Laurell, CG; Zetterström, C, 2002) |
| "Latanoprost therapy enhances disruption of the blood-aqueous barrier and increases the incidence of angiographic CME formation in early postoperative pseudophakias." | 5.09 | Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias. ( Ichihashi, S; Maekubo, K; Miyake, K; Miyake, S; Ota, I, 1999) |
| " The concurrent administration of nonsteroidal anti-inflammatory drug such as diclofenac prevents these adverse effects without interfering with the drop in intraocular pressure caused by timolol." | 5.09 | Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia. ( Akura, J; Ibaraki, N; Ichihashi, S; Maekubo, K; Miyake, K; Miyake, S; Ota, I; Shibuya, Y, 2001) |
| " For prevention of postoperative intraocular pressure (IOP) elevation, carbachol 0." | 5.08 | [Minimally inflammatory cataract surgery]. ( Hessemer, V; Schartner, H; Schmidt, KG, 1996) |
| "In eyes with low to moderate myopia, the steroid and diclofenac subgroups had significantly different refractions 2 and 4 months postoperatively but no difference at 6 months; subjective haze grading was consistently lower in the steroid subgroup than in the NSAID subgroups (flurbiprofen, diclofenac) after 2 months." | 5.08 | Short-term effects of flurbiprofen and diclofenac on refractive outcome and corneal haze after photorefractive keratectomy. ( Baek, SH; Chang, JH; Choi, SY; Lee, JH; Wee, WR, 1997) |
| "In the diclofenac group (n = 14), the preoperative intraocular pressure of 30." | 5.08 | The efficacy and safety of diclofenac 0.1% versus prednisolone acetate 1% following trabeculectomy with adjunctive mitomycin-C. ( Cate, EA; Dubiner, HB; Kent, AR; Mundorf, TK; Stewart, JA; Stewart, WC; Whitaker, R, 1998) |
| "To evaluate effects of topical ophthalmic administration of diclofenac on intraocular pressure (IOP) when applied at 4 frequencies to eyes of Beagles." | 3.96 | Effect of topical administration of 0.1% diclofenac sodium ophthalmic solution at four frequencies on intraocular pressure in healthy Beagles. ( Colussi, JA; Henriksen, ML; Lappin, MR; Martabano, BB; Sharp, JL; Wang, Z, 2020) |
| "To evaluate the effect of a single dose of intravitreal diclofenac on macular edema (ME) due to branch retinal vein occlusion (BRVO)." | 3.83 | Intravitreal Diclofenac in the Treatment of Macular Edema Due to Branch Retinal Vein Occlusion. ( Arora, S; Ghosh, B; Gupta, A; Raina, UK; Seth, A, 2016) |
| "To compare the effects of topical diclofenac sodium with those of fluorometholone on intraocular pressure (IOP) and conjunctival inflammation after strabismus surgery." | 3.80 | Diclofenac versus fluorometholone after strabismus surgery in children. ( Han, SB; Hwang, JM; Yang, HK, 2014) |
| "Forty-two diabetic patients and 50 normal control patients who underwent small-incision phacoemulsification cataract surgery bilaterally received topical preservative-free diclofenac in 1 eye and preserved diclofenac in the other eye." | 3.78 | A comparison of preservative-free diclofenac and preserved diclofenac eye drops after cataract surgery in patients with diabetic retinopathy. ( Miyazawa, A; Shimura, M; Yasuda, K, 2012) |
| " Topical administration of diclofenac and flurbiprofen should be used with caution in cats with a history of ocular hypertension." | 3.77 | Evaluation of four drugs for inhibition of paracentesis-induced blood-aqueous humor barrier breakdown in cats. ( Khrone, SG; Rankin, AJ; Stiles, J, 2011) |
| "To clarify the intraocular pressure (IOP)-lowering profile of tafluprost, a newly synthesised prostaglandin F(2alpha) analogue, in mice." | 3.74 | The IOP-lowering effects and mechanism of action of tafluprost in prostanoid receptor-deficient mice. ( Aihara, M; Araie, M; Narumiya, S; Ota, T; Saeki, T, 2007) |
| "This prospective non-comparative case series followed 77 eyes of 63 patients which showed signs of threatened early bleb failure and were treated with oral anti-inflammatory fibrosis suppression of prednisone, a non-steroidal anti-inflammatory agent, and colchicine taken for a mean period of 6 weeks, in addition to standard postoperative topical treatment, for a mean follow up of 6 years." | 3.71 | Anti-inflammatory fibrosis suppression in threatened trabeculectomy bleb failure produces good long term control of intraocular pressure without risk of sight threatening complications. ( Bevin, TH; Fuller, JR; Herbison, P; Molteno, AC; Vote, BJ, 2002) |
| "To investigate the mechanism by which pilocarpine causes increased aqueous humor (AH) flare, hypotony, and miosis in dogs." | 3.70 | Inhibition of pilocarpine-induced aqueous humor flare, hypotony, and miosis by topical administration of anti-inflammatory and anesthetic drugs to dogs. ( Gionfriddo, J; Krohne, SG; Morrison, EA, 1998) |
| "005% latanoprost alone and in combination with 0." | 2.84 | Effect of topical ophthalmic latanoprost 0.005% solution alone and in combination with diclofenac 0.1% solution in healthy horses: a pilot study. ( Allbaugh, R; Ben-Shlomo, G; Griggs, A; Strong, T; Tofflemire, K; Whitley, EM; Whitley, RD, 2017) |
| "The intraocular pressures were measured at regular intervals during the 6-months follow-up period." | 2.80 | Influence on intraocular pressure of anti-inflammatory treatments after selective laser trabeculoplasty. ( Anctil, JL; Champagne, S; Des Marchais, B; Goyette, A; Lajoie, C, 2015) |
| "Diclofenac was more effective than betamethasone in preventing angiographic CME and BAB disruption after small-incision cataract surgery." | 2.73 | Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethason ( Asano, S; Kimura, W; Miyake, K; Ota, I; Sakka, Y; Sugita, G; Yabe, N, 2008) |
| "Diclofenac-treated patients exhibited a marked fall in intraocular pressure (p<0." | 2.71 | The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients. ( Antinozzi, PP; Caccavale, A; Costagliola, C; Cotticelli, L; Parmeggiani, F; Sebastiani, A, 2005) |
| " Side effect incidence and patient and investigator opinions were also recorded." | 2.69 | Tolerability and safety of 0.1% diclofenac plus 0.3% tobramycin fixed-dose ophthalmic solution: a randomized, comparative, controlled study in healthy volunteers. ( Andreu, D; Costa, J; Martínez, M; Notivol, R; Salvá, P, 1999) |
| "In the dosage used, diclofenac was as effective an anti-inflammatory agent for uncomplicated post-cataract inflammation as prednisolone." | 2.68 | A comparison of topical diclofenac with prednisolone for postcataract inflammation. ( Brennan, KM; Roberts, CW, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (3.92) | 18.7374 |
| 1990's | 17 (33.33) | 18.2507 |
| 2000's | 17 (33.33) | 29.6817 |
| 2010's | 12 (23.53) | 24.3611 |
| 2020's | 3 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Weber, A | 1 |
| Casini, A | 1 |
| Heine, A | 1 |
| Kuhn, D | 1 |
| Supuran, CT | 1 |
| Scozzafava, A | 1 |
| Klebe, G | 1 |
| Martabano, BB | 1 |
| Henriksen, ML | 1 |
| Colussi, JA | 1 |
| Sharp, JL | 1 |
| Wang, Z | 1 |
| Lappin, MR | 1 |
| Cagini, C | 1 |
| Pellegrino, A | 1 |
| Cerquaglia, A | 1 |
| Iaccheri, B | 1 |
| Lupidi, M | 1 |
| Fiore, T | 1 |
| Thrane, VR | 1 |
| Thrane, AS | 1 |
| Bergo, C | 1 |
| Halvorsen, H | 1 |
| Krohn, J | 1 |
| Kim, J | 1 |
| Choi, DC | 1 |
| Bae, S | 1 |
| Choi, DG | 1 |
| Lee, JY | 1 |
| Yang, HK | 1 |
| Han, SB | 1 |
| Hwang, JM | 1 |
| Champagne, S | 1 |
| Anctil, JL | 1 |
| Goyette, A | 1 |
| Lajoie, C | 1 |
| Des Marchais, B | 1 |
| Lee, TH | 1 |
| Choi, W | 1 |
| Ji, YS | 1 |
| Yoon, KC | 1 |
| Seth, A | 1 |
| Ghosh, B | 1 |
| Raina, UK | 1 |
| Gupta, A | 1 |
| Arora, S | 1 |
| Tofflemire, K | 1 |
| Whitley, EM | 1 |
| Allbaugh, R | 1 |
| Ben-Shlomo, G | 1 |
| Griggs, A | 1 |
| Strong, T | 1 |
| Whitley, RD | 1 |
| Maca, SM | 1 |
| Amon, M | 1 |
| Findl, O | 1 |
| Kahraman, G | 1 |
| Barisani-Asenbauer, T | 1 |
| Rankin, AJ | 1 |
| Khrone, SG | 1 |
| Stiles, J | 1 |
| Tilma, KK | 1 |
| Bek, T | 1 |
| Elbendary, AM | 1 |
| Shahin, MM | 1 |
| Levkovitch-Verbin, H | 1 |
| Katz, G | 1 |
| Kalev-Landoi, M | 1 |
| Goldenfeld, M | 1 |
| Yasuda, K | 2 |
| Miyazawa, A | 1 |
| Shimura, M | 2 |
| Fuller, JR | 1 |
| Bevin, TH | 1 |
| Molteno, AC | 1 |
| Vote, BJ | 1 |
| Herbison, P | 1 |
| Laurell, CG | 1 |
| Zetterström, C | 1 |
| Scuderi, B | 1 |
| Driussi, GB | 1 |
| Chizzolini, M | 1 |
| Salvetat, ML | 1 |
| Beltrame, G | 1 |
| Stewart, WC | 3 |
| Costagliola, C | 1 |
| Parmeggiani, F | 1 |
| Antinozzi, PP | 1 |
| Caccavale, A | 1 |
| Cotticelli, L | 1 |
| Sebastiani, A | 1 |
| Satav, SS | 1 |
| Thomas, R | 1 |
| Kahana, A | 1 |
| Ota, T | 2 |
| Aihara, M | 2 |
| Saeki, T | 2 |
| Narumiya, S | 2 |
| Araie, M | 2 |
| Akyol-Salman, I | 1 |
| Leçe-Sertöz, D | 1 |
| Baykal, O | 1 |
| Nakazawa, T | 1 |
| Nishida, K | 1 |
| Asano, S | 1 |
| Miyake, K | 3 |
| Ota, I | 3 |
| Sugita, G | 1 |
| Kimura, W | 1 |
| Sakka, Y | 1 |
| Yabe, N | 1 |
| Wheeldon, CE | 1 |
| Hadden, OB | 1 |
| Niederer, RL | 1 |
| McGhee, CN | 1 |
| Kim, SJ | 1 |
| Adams, NA | 1 |
| Toma, HS | 1 |
| Belair, ML | 1 |
| Thorne, JE | 1 |
| Green, WR | 1 |
| Jabs, DA | 1 |
| Agata, M | 1 |
| Abe, T | 1 |
| Kon, M | 1 |
| Tanaka, M | 1 |
| Kimura, T | 1 |
| Nakajima, A | 1 |
| Roberts, CW | 1 |
| Brennan, KM | 1 |
| Constable, PH | 1 |
| Adams, GG | 1 |
| Gwin, TD | 1 |
| Gwynn, DR | 1 |
| Herbort, CP | 2 |
| Mermoud, A | 2 |
| Schnyder, C | 2 |
| Pittet, N | 2 |
| Diestelhorst, M | 2 |
| Thull, D | 1 |
| Krieglstein, GK | 1 |
| Hessemer, V | 1 |
| Schmidt, KG | 1 |
| Schartner, H | 1 |
| Ustundag, C | 1 |
| Baek, SH | 1 |
| Choi, SY | 1 |
| Chang, JH | 1 |
| Wee, WR | 1 |
| Lee, JH | 1 |
| Krohne, SG | 1 |
| Gionfriddo, J | 1 |
| Morrison, EA | 1 |
| el-Harazi, SM | 1 |
| Ruiz, RS | 1 |
| Feldman, RM | 1 |
| Villanueva, G | 1 |
| Chuang, AZ | 1 |
| Kent, AR | 1 |
| Dubiner, HB | 1 |
| Whitaker, R | 1 |
| Mundorf, TK | 1 |
| Stewart, JA | 1 |
| Cate, EA | 1 |
| Koçak, I | 1 |
| Yalvaç, IS | 1 |
| Koçak, A | 1 |
| Nurözler, A | 1 |
| Unlü, N | 1 |
| Kasim, R | 1 |
| Duman, S | 1 |
| Maekubo, K | 2 |
| Ichihashi, S | 2 |
| Miyake, S | 2 |
| Salvá, P | 1 |
| Costa, J | 1 |
| Andreu, D | 1 |
| Notivol, R | 1 |
| Martínez, M | 1 |
| Snir, M | 1 |
| Axer-Siegel, R | 1 |
| Friling, R | 1 |
| Weinberger, D | 1 |
| Ibaraki, N | 1 |
| Akura, J | 1 |
| Shibuya, Y | 1 |
| Strelow, SA | 1 |
| Sherwood, MB | 1 |
| Broncato, LJ | 1 |
| Napier, A | 1 |
| Driebe, WT | 1 |
| Guy, JR | 1 |
| Vickers, FF | 1 |
| Mellars, K | 1 |
| Castillo Laguarta, J | 1 |
| Loras Alegre, E | 1 |
| Minana Beamonte, I | 1 |
| Ascaso Puyuelo, J | 1 |
| Garcia Garcia, J | 1 |
| Palomar Gomez, A | 1 |
| Cristobal Bescos, JA | 1 |
| Pillunat, LE | 1 |
| Wagner, P | 1 |
| Stodtmeister, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomised Control Study to Investigate if the Continuation of Prostaglandin Analogue Treatments in the Post-operative Phase of Glaucoma Patients Undergoing Cataract Surgery Increases the Incidence of Cystoid Macular Oedema.[NCT03292796] | Phase 2 | 56 participants (Actual) | Interventional | 2016-12-07 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
34 trials available for diclofenac and Intraocular Pressure
| Article | Year |
|---|---|
Comparison of the Effect of Diclofenac 0.1% and Nepafenac 0.1% on Aqueous Flare in Patients Undergoing Cataract Surgery: A Prospective Randomized Study.
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aqueou | 2020 |
Effect of Apraclonidine and Diclofenac on Early Changes in Intraocular Pressure After Selective Laser Trabeculoplasty.
Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Anti-Inflammatory Agents, Non-Steroidal; Clonidine; Dicl | 2020 |
A Randomized Clinical Trial of Topical Diclofenac, Fluorometholone, and Dexamethasone for Control of Inflammation After Strabismus Surgery.
Topics: Administration, Topical; Adolescent; Adult; Child; Dexamethasone; Diclofenac; Female; Fluorometholon | 2018 |
Influence on intraocular pressure of anti-inflammatory treatments after selective laser trabeculoplasty.
Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Clonidine; Combined Modalit | 2015 |
Effect of topical ophthalmic latanoprost 0.005% solution alone and in combination with diclofenac 0.1% solution in healthy horses: a pilot study.
Topics: Administration, Topical; Animals; Antihypertensive Agents; Diclofenac; Double-Blind Method; Drug The | 2017 |
Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzalkonium Compounds; Diclofenac | 2010 |
Topical treatment for 1 week with latanoprost but not diclofenac reduces the diameter of dilated retinal arterioles in patients with type 1 diabetes mellitus and mild retinopathy.
Topics: Administration, Topical; Adult; Antihypertensive Agents; Arterioles; Blood Glucose; Blood Pressure; | 2012 |
Intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diabetic Retinopathy; Diclofenac; Female; Glucocorti | 2011 |
Postoperative treatment with topical diclofenac versus topical dexamethasone after combined phacotrabeculectomy with mitomycin C.
Topics: Administration, Topical; Aged; Alkylating Agents; Anti-Inflammatory Agents, Non-Steroidal; Cataract; | 2013 |
Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery.
Topics: Aged; Aged, 80 and over; Cataract Extraction; Dexamethasone; Diclofenac; Double-Blind Method; Eye Di | 2002 |
Effectiveness and tolerance of piroxicam 0.5% and diclofenac sodium 0.1% in controlling inflammation after cataract surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diclofena | 2003 |
Prevention of corticosteroid-induced intraocular pressure elevation using ISV-205.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; D | 2003 |
The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Aged; Analysis of Variance; Anti-Inflammatory | 2005 |
Topical pranoprofen 0.1% is as effective anti-inflammatory and analgesic agent as diclofenac sodium 0.1% after strabismus surgery.
Topics: Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Benzopyrans; Ch | 2007 |
Diclofenac prevents an early event of macular thickening after cataract surgery in patients with diabetes.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents | 2007 |
Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethason
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Blood-Aqueous | 2008 |
A comparison of topical diclofenac with prednisolone for postcataract inflammation.
Topics: Administration, Topical; Anterior Chamber; Cataract Extraction; Cell Count; Diclofenac; Double-Blind | 1995 |
Use of topical diclofenac in association with external ocular compression.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Diclofenac; Humans; Intraocular Pressure; M | 1994 |
Anti-inflammatory effect of diclofenac drops after argon laser trabeculoplasty.
Topics: Aged; Anterior Eye Segment; Diclofenac; Double-Blind Method; Drug Administration Schedule; Endophtha | 1993 |
The effect of argon laser trabeculoplasty on the blood-aqueous barrier and intraocular pressure in human glaucomatous eyes treated with diclofenac 0.1%.
Topics: Anterior Chamber; Anti-Inflammatory Agents, Non-Steroidal; Blood-Aqueous Barrier; Diclofenac; Female | 1995 |
[Minimally inflammatory cataract surgery].
Topics: Adult; Aged; Aged, 80 and over; Blood-Aqueous Barrier; Carbachol; Dexamethasone; Dichlorphenamide; D | 1996 |
Efficacy of argon laser trabeculoplasty: 3-year preliminary results of a prospective placebo-controlled study.
Topics: Adult; Aged; Aged, 80 and over; Cyclooxygenase Inhibitors; Diclofenac; Disease Progression; Exfoliat | 1997 |
Short-term effects of flurbiprofen and diclofenac on refractive outcome and corneal haze after photorefractive keratectomy.
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cornea; Corneal Opacity; D | 1997 |
A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; C | 1998 |
The efficacy and safety of diclofenac 0.1% versus prednisolone acetate 1% following trabeculectomy with adjunctive mitomycin-C.
Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Chemotherapy, Adjuvant; Chr | 1998 |
Comparison of the anti-inflammatory effects of diclofenac and flurbiprofen eye drops after cataract extraction.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cataract Extraction; Cornea; Diclofenac; Double-Blind | 1998 |
Latanoprost accelerates disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias.
Topics: Aged; Blood-Aqueous Barrier; Cataract Extraction; Diclofenac; Double-Blind Method; Female; Fluoresce | 1999 |
Tolerability and safety of 0.1% diclofenac plus 0.3% tobramycin fixed-dose ophthalmic solution: a randomized, comparative, controlled study in healthy volunteers.
Topics: Adolescent; Adult; Conjunctiva; Cross-Over Studies; Diclofenac; Double-Blind Method; Drug Combinatio | 1999 |
Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery.
Topics: Adolescent; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Prescho | 2000 |
Enhanced disruption of the blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Aged; Anterior Eye Segment; Anti-Inflammatory | 2001 |
The effect of diclofenac sodium ophthalmic solution on intraocular pressure following cataract extraction.
Topics: Aged; Cataract Extraction; Diclofenac; Double-Blind Method; Female; Follow-Up Studies; Humans; Incid | 1992 |
[Anti-inflammatory effect of topical diclofenac sodium (Voltarène Ophta) after argon laser trabeculoplasty: preliminary results of a prospective double-blind method].
Topics: Aged; Anterior Chamber; Diclofenac; Double-Blind Method; Female; Glaucoma; Glaucoma, Open-Angle; Hum | 1992 |
[Influence of topical administration of diclofenac on the reduction of intraocular pressure induced by timolol in healthy subjects].
Topics: Administration, Topical; Depression, Chemical; Diclofenac; Double-Blind Method; Drug Evaluation; Dru | 1991 |
[Comparison of locally applied prostaglandin synthesis inhibitors in Nd:YAG laser surgery--initial results].
Topics: Aged; Cataract Extraction; Clinical Trials as Topic; Diclofenac; Humans; Indomethacin; Intraocular P | 1987 |
17 other studies available for diclofenac and Intraocular Pressure
| Article | Year |
|---|---|
Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition.
Topics: Animals; Binding Sites; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Celecoxib; Crystallograp | 2004 |
Effect of topical administration of 0.1% diclofenac sodium ophthalmic solution at four frequencies on intraocular pressure in healthy Beagles.
Topics: Administration, Ophthalmic; Administration, Topical; Animals; Diclofenac; Dogs; Drug Administration | 2020 |
Diclofenac versus fluorometholone after strabismus surgery in children.
Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Conjuncti | 2014 |
Comparison of ketorolac 0.45% versus diclofenac 0.1% for macular thickness and volume after uncomplicated cataract surgery.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Humans; Intrao | 2016 |
Intravitreal Diclofenac in the Treatment of Macular Edema Due to Branch Retinal Vein Occlusion.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Fluorescein Angiography; F | 2016 |
Evaluation of four drugs for inhibition of paracentesis-induced blood-aqueous humor barrier breakdown in cats.
Topics: Animals; Anterior Chamber; Anti-Inflammatory Agents; Aqueous Humor; Blood-Aqueous Barrier; Cat Disea | 2011 |
A comparison of preservative-free diclofenac and preserved diclofenac eye drops after cataract surgery in patients with diabetic retinopathy.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Case-Control Studies; Cataract; Cataract Extracti | 2012 |
Anti-inflammatory fibrosis suppression in threatened trabeculectomy bleb failure produces good long term control of intraocular pressure without risk of sight threatening complications.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Diclofenac; Dru | 2002 |
Preventing steroid-induced glaucoma.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Glaucoma, Open-Angle; Glucocorticoids; Humans; | 2005 |
Prevention of steroid-induced intraocular pressure elevation.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cytoskeletal Proteins; Diclofenac; Drug Delivery Systems; E | 2005 |
The effects of prostaglandin analogues on prostanoid EP1, EP2, and EP3 receptor-deficient mice.
Topics: Animals; Antihypertensive Agents; Circadian Rhythm; Diclofenac; Intraocular Pressure; Mice; Mice, In | 2006 |
The IOP-lowering effects and mechanism of action of tafluprost in prostanoid receptor-deficient mice.
Topics: Administration, Topical; Animals; Antihypertensive Agents; Diclofenac; Intraocular Pressure; Mice; M | 2007 |
Presumed late diffuse lamellar keratitis progressing to interface fluid syndrome.
Topics: Adult; Body Fluids; Corneal Stroma; Diclofenac; Drug Therapy, Combination; Humans; Intraocular Press | 2008 |
Safety of intravitreal ketorolac and diclofenac: an electroretinographic and histopathologic study.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dark Adaptation; Diclofenac; Electroretinography; | 2008 |
[Effect of topical diclofenac sodium, a non-steroidal anti-inflammatory drug, on various ocular inflammatory models in animals].
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Aqueous Humor; Diclofenac; Eye Diseases; | 1983 |
Filtration surgery in rabbits treated with diclofenac or prednisolone acetate.
Topics: Animals; Combined Modality Therapy; Diclofenac; Endophthalmitis; Glaucoma; Intraocular Pressure; Pre | 1994 |
Inhibition of pilocarpine-induced aqueous humor flare, hypotony, and miosis by topical administration of anti-inflammatory and anesthetic drugs to dogs.
Topics: Administration, Topical; Anesthetics, Local; Animals; Anti-Inflammatory Agents; Aqueous Humor; Diclo | 1998 |